2025 United States Apheresis Market Revenue Opportunities Report
Description
The 2025 United States Apheresis Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Apheresis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the U.S. apheresis market are Haemonetics Corporation, Fresenius Kabi (Fresenius Medical Care), B. Braun SE, and Terumo Corporation (Terumo BCT Inc.). Haemonetics is recognized for its advanced blood management technologies and strategic partnerships with academic and medical institutions, which enhance its innovation capabilities and market presence. Fresenius Kabi, a key player in therapeutic apheresis, focuses on cutting-edge platforms and extensive global reach. B. Braun SE and Terumo BCT also hold significant shares through continuous R&D, product launches, and collaborations with healthcare providers.
These companies benefit from the growing demand driven by the rising incidence of chronic diseases such as cancer, autoimmune disorders, and kidney diseases in the U.S. The market is supported by advanced healthcare infrastructure, regulatory frameworks from the FDA, and increasing awareness of apheresis benefits over traditional treatments. Strategic initiatives like mergers and acquisitions, digital health integration, and geographic expansion further strengthen their competitive positions. Their investments focus on improving device efficiency, patient comfort, and enabling personalized treatment options.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Apheresis Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the U.S. apheresis market are Haemonetics Corporation, Fresenius Kabi (Fresenius Medical Care), B. Braun SE, and Terumo Corporation (Terumo BCT Inc.). Haemonetics is recognized for its advanced blood management technologies and strategic partnerships with academic and medical institutions, which enhance its innovation capabilities and market presence. Fresenius Kabi, a key player in therapeutic apheresis, focuses on cutting-edge platforms and extensive global reach. B. Braun SE and Terumo BCT also hold significant shares through continuous R&D, product launches, and collaborations with healthcare providers.
These companies benefit from the growing demand driven by the rising incidence of chronic diseases such as cancer, autoimmune disorders, and kidney diseases in the U.S. The market is supported by advanced healthcare infrastructure, regulatory frameworks from the FDA, and increasing awareness of apheresis benefits over traditional treatments. Strategic initiatives like mergers and acquisitions, digital health integration, and geographic expansion further strengthen their competitive positions. Their investments focus on improving device efficiency, patient comfort, and enabling personalized treatment options.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
